Gut microbiota dysbiosis features progressive HIV infection, with subsequent microbial translocation and systemic immune activation. Still, the microbial composition in gut of elite controllers (EC) has not been extensively explored, neither the corresponding metabolic pathways.
16 EC and 32 ART naïve progressors were recruited from a Swedish HIV cohort, and also 16 healthy controls (HC). Subjects were matched by age, gender and sexual practice. Fecal microbiota composition was determined by 16S rRNA sequencing. Plasma markers of tryptophan catabolism pathway were analyzed by HPLC. Functional content of the bacterial 16srRNA metagenome was inferred by PICRUSt software.
The number of observed genera was significantly higher in EC vs progressors (median 87 vs 70; HC 78), and several α-diversity indexes were lower in patients with progressive infection (median Chao1: 95 vs 80, ACE: 93 vs 79; in HC 83 and 85, respectively). At genus level, Succinivibrio, Sutterella, Rhizobium, Delftia, Anaerofilum and Oscillospira were more abundant in EC, whereas Blautia and Anaerostipes were depleted. Plasma K/T ratio was significantly increased in progressors as compared to EC and HC. The PICRUSt analysis revealed several significant differences between groups in different metabolic pathways. Carbohydrate metabolism pathway was less represented in EC fecal microbiome. Conversely, several other metabolic pathways (fatty acid metabolism, PPAR-signalling and lipid biosynthesis proteins) were enriched in EC than in progressors. Secondary, bile acid synthesis pathway was underrepresented in EC as compared to naïve progressors and HC. Additionally, pathways related to pentose-phosphate (PPP), pentose-glucoronate interconversions, and phenylalanine-tyrosine-tryptophan biosynthesis were reduced both in EC and HC when compared to naïve progressors. Differences between EC and HC were less frequent and included pathways related to carbohydrate metabolism, biosynthesis and biodegradation of secondary metabolites, PPP and bacterial toxins.
EC have a richer gut microbiota than untreated HIV patients, with a unique bacterial signature at genus level. We confirm that tryptophan metabolism is altered during HIV infection, mostly in naive progressors. Functional analysis of the 16srRNA metagenome shows that EC have a distinct profile in several metabolic pathways, including metabolism of carbohydrates, lipids and tryptophan.